WHO started its drug trial with antimalarial and antiviral drugs in a way to combat the pandemic. While both the trails we’re on track, a recent report by the organization said it is temporarily stopping the antimalarial drugs for the trial, Fox News reports. This is because patients in hospitals have known to have a higher mortality rate after taking the drug. Therefore, a temporary pause will be made and allow the agency to review all the evidence regarding the safety concerns of the drug while treating COVID-19 patients, said the director-general.
This decision comes after that fact, a recent review published in The Lancet saying that drugs are causing higher mortality with cardiac effects. The researchers also concluded that they were unable to confirm the benefit of the drugs when used alone or with an antibiotic against COVID-19. On the other hand, the director-general also said these drugs are safer when it comes to treating malaria and other disorders. WHO emergency chief also added that there are no safety problems recorded to date in the trial. They are also acting on the caution reports that’s been coming in relating the safety of the drug so that they can continue the trial safely. While the malaria trial is getting stopped, we should see that the antiviral drug trial is still on the roll to fight the disease.
President of the US also stated that he’s been taking the drug for almost two weeks with zinc supplements. This raises concerns as physicians and health workers advise people not to take drugs on their own without the guidance of physicians. Not to forget, people ate fish tank cleaning agents with hydroxychloroquine mistaking it as the drug. The FDA also wanted not to take the drugs outside the hospital environment as it may cause fatal heart rhythms.
Do you want to publish on Apple News, Google News, and more? Join our writing community, improve your writing skills, and be read by hundreds of thousands around the world!